-82%

est. 2Y upside i

Series A

Mason is the fastest way to take smart devices from idea to end user

Rank

#3981

Sector

Enterprise Software

Est. Liquidity

~4Y

Data Quality

Data: Medium

Mason presents a risky equity opportunity for a job seeker.

Last updated: March 10, 2026

Bull (10%)+250%

Mason successfully leverages its specialized platform for dedicated smart devices, particularly in the clinical trial technology segment, accelerating growth to 40%+ YoY. This allows for a successful Series B round at a significantly higher valuation, reaching $525M by 2028 (3.5x current valuation) and a strong exit within 4 years.

Base (40%)+30%

Mason maintains its niche market position with modest growth of 15-20% YoY, reaching approximately $35M in revenue by 2026. The company secures additional funding, but at a flat or slightly up round, leading to a modest valuation increase to $195M, offering limited upside for common shareholders.

Bear (50%)-80%

Slow growth persists, exacerbated by increased competition from large incumbents expanding their IoT and enterprise mobility offerings. Mason struggles to raise further capital, leading to a down round or a distressed acquisition, resulting in a valuation below $50M and significant loss of common stock value due to liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Investors hold $25M in liquidation preferences ahead of common stock. In an exit at or below the $150M current valuation, common shareholders would receive value only after the $25M preference is paid.

Dilution Risk

high

With only $25M raised and slow growth, more funding rounds are highly likely, leading to further dilution for existing common shareholders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for a company at this stage with this funding profile.

Questions to Ask at the Interview

Strategic questions based on Mason's data — designed to show you've done your homework.

  • 1

    “Given Mason's reported revenue growth since its Series A in 2019, how does the company plan to significantly accelerate its market penetration and achieve a higher growth trajectory, especially in the competitive IoT device management and enterprise mobility markets?”

  • 2

    “With large incumbents like Microsoft and AWS having extensive IoT platforms, and established players like Jamf in device management, what is Mason's specific strategy to differentiate and capture significant market share, particularly in the clinical trial technology segment?”

  • 3

    “Considering the Series A funding was in 2019 and there haven't been public subsequent rounds, how does the company envision its next funding event or liquidity path for employees, and what milestones are critical to achieving that?”

Community

Valuation Sentiment

Our model estimates -82% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.